The following video is from Tuesday's edition of Market Foolery, in which host Chris Hill and Motley Fool analysts Matt Argersinger and Jason Moser take a deep dive into today's best investing news.
Shares of Johnson & Johnson (NYSE: JNJ ) got a small boost after the company beat expectations on Q3 profits, in part because of a strong performance from the company's drug division. In this segment, Matt and Jason look at this Dow mega blue chip, and tell investors whether the company is a buy today.
Looking for great dividends?
If you're looking for some long-term investing ideas, you're invited to check out The Motley Fool's brand-new special report, "The 3 Dow Stocks Dividend Investors Need." It's absolutely free, so simply click here now and get your copy today.